Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 25, 2025
Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025
GlobeNewswire
·
April 25, 2025
TARPON SPRINGS, Fla., April 25, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a …
Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”
GlobeNewswire
·
April 25, 2025
DURHAM, N.C., April 25, 2025 (GLOBE NEWSWIRE) -- Codetta Bio is proud to announce the official launch of the Concerto™ System, a revolutionary new multi-omics platform, at the American Association for Cancer Research (AACR) Annual Meeting 2025. The …
VYNE Therapeutics Provides Update on VYN202 Program
GlobeNewswire
·
April 25, 2025
BRIDGEWATER, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) verbally informed the Company that it placed a clinical hold on the …
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
GlobeNewswire
·
April 25, 2025
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection with the …
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
GlobeNewswire
·
April 25, 2025
Vancouver, Canada, April 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
GlobeNewswire
·
April 25, 2025
SHANGHAI, April 25, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …
Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!
GlobeNewswire
·
April 25, 2025
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- Flush Factor Plus is a natural dietary supplement that claims to support fluid retention and promote joint mobility and flexibility. Knee pain and joint issues due to improper fluid circulation are common issues …
Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ
GlobeNewswire
·
April 25, 2025
New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Struggling with constant cravings or late-night snacking? You're not alone. In 2025, appetite control has become one of the most critical challenges in any successful weight loss journey. That’s why …
Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
GlobeNewswire
·
April 25, 2025
Raanana, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the successful …
Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
Media Advisory - 2025 Virtual Reality Expo: Accelerating Innovation in Healthcare
GlobeNewswire
·
April 25, 2025
MONTREAL, April 25, 2025 (GLOBE NEWSWIRE) -- Media representatives are invited to the 2025 edition of the VR Expo: Accelerating Innovation in Health Care, an immersive event that explores the potential of virtual reality (VR) in specialized pediatric care. …
Avis aux médias - Exposition Réalité Virtuelle 2025 : Accélérer l'innovation en matière de soins de santé
GlobeNewswire
·
April 25, 2025
MONTRÉAL, 25 avr. 2025 (GLOBE NEWSWIRE) -- Les représentants des médias sont cordialement invités à l’édition 2025 de la RV Expo : accélérer l’innovation en matière de soins de santé, un événement immersif qui explore le potentiel de la réalité virtuelle ( …
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
GlobeNewswire
·
April 25, 2025
BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …
CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.
GlobeNewswire
·
April 25, 2025
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- CPOINT Capital Corp. (“CPOINT”) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (“Juno”) acquired 1,875,000 common shares (the “Common Shares”) in the capital of Conavi Medical …
Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda
GlobeNewswire
·
April 25, 2025
April 25, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) provides an update on the Annual General Meeting 2025 which has been convened on March 24, 2025 (AGM). As previously announced, the AGM agenda includes the proposal to appoint …
A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States
GlobeNewswire
·
April 25, 2025
LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an average of 17 Veterans lost to …
Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia
GlobeNewswire
·
April 25, 2025
First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea. Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified …
Best Thermogenic Fat Burner Supplements 2025: Top Fat Burning Pills for Weight Loss From PhenQ
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of fitness and fat loss, thermogenic fat burners have emerged as some of the most powerful and popular weight loss tools available today. As we move into 2025, demand for effective fat …
SYNC Sunlight Loophole Under Review: Unique Metabolism Boosting Formula to Burn Belly Fat Fast
GlobeNewswire
·
April 25, 2025
Aurora, Colorado, April 25, 2025 (GLOBE NEWSWIRE) -- If you've ever felt like your body is stuck in weight loss mode off, you're not alone. Millions of people follow diets, try new workouts, and commit to healthier habits, yet the stubborn belly fat stays …